Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Osteoporosis

Free Subscription 25.08.2025 1 Drugs Aging 3 J Bone Miner Res 1 J Clin Endocrinol Metab 1 J Clin Invest 12 Osteoporos Int

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Drugs Aging

1. SCORTICHINI M, Dilecce M, Spelta M, Sammak S, et al
   Correction: Burden of Disease and Treatment Gap in Patients with an Osteoporotic Hip Fracture between 2015 and 2019 in Italy.
   Drugs Aging. 2025 Aug 26. doi: 10.1007/s40266-025-01223.
   PubMed        
   
   

   
   J Bone Miner Res

2. ADAMI G, Montanari F, Fassio A, Pollastri F, et al
   Increase in Serum DKK1 Levels Attenuates the Anabolic Response to Romosozumab in Postmenopausal Osteoporosis.
   J Bone Miner Res. 2025 Aug 19:zjaf110. doi: 10.1093.
   PubMed         Abstract available
   
   
3. SYME CA, Cicero MD, Adachi JD, Berger C, et al
   Fracture Risk Scores Using Output from an Opportunistic Screen of Low Bone Density from Conventional X-ray.
   J Bone Miner Res. 2025 Aug 19:zjaf113. doi: 10.1093.
   PubMed         Abstract available
   
   
4. BUGBIRD AR, Whittier DE, Burt LA, Boyd SK, et al
   Longitudinal Associations Between Changes in Bone Mechanical Strength and Fracture Risk Estimated by FRAC.
   J Bone Miner Res. 2025 Aug 18:zjaf111. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Clin Endocrinol Metab

5. DICKENS LT, Abe CM, Connors M, Osman F, et al
   Osteoporosis Epidemiology, Diagnosis, and Management Across Race and Ethnicity in the United States.
   J Clin Endocrinol Metab. 2025 Aug 18:dgaf466. doi: 10.1210.
   PubMed         Abstract available
   
   

   
   J Clin Invest

6. HENNEN EM, Uppuganti S, de la Visitacion N, Chen W, et al
   Hypertension promotes bone loss and fragility by favoring bone resorption in mouse models.
   J Clin Invest. 2025 Aug 19:e184325. doi: 10.1172/JCI184325.
   PubMed         Abstract available
   
   

   
   Osteoporos Int

7. SCHOTT EM, Charbonneau MR, Kiel DP, Bukata S, et al
   A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy of the synbiotic medical food, SBD111, for the clinical dietary management of bone loss in menopausal women.
   Osteoporos Int. 2025 Aug 15. doi: 10.1007/s00198-025-07650.
   PubMed         Abstract available
   
   
8. MCCLOSKEY EV, Johansson H, Liu E, Akesson KE, et al
   Family history of fracture and fracture risk: a meta-analysis to update the FRAX(R) risk assessment tool.
   Osteoporos Int. 2025 Aug 23. doi: 10.1007/s00198-025-07607.
   PubMed         Abstract available
   
   
9. CHEN J, Cao L, Xu C, Lu F, et al
   Modified criteria for identifying elevated bone mass.
   Osteoporos Int. 2025;36:1433-1445.
   PubMed         Abstract available
   
   
10. PELEPENKO LE, de Oliveira MC, Masaro DA, Lustosa GMMM, et al
    Effects of microplastics on the bones: a comprehensive review.
    Osteoporos Int. 2025;36:1327-1345.
    PubMed         Abstract available
    
    
11. ZHAO AY, Chiu A, Agarwal AR, Harris AB, et al
    The growing burden of periprosthetic fractures after total hip arthroplasty: identifying overall trends and at-risk groups.
    Osteoporos Int. 2025 Jun 26. doi: 10.1007/s00198-025-07583.
    PubMed         Abstract available
    
    
12. DEMERS AJ, Fitton LS, McCulley SML, Delgado-Arellanes I, et al
    Fracture liaison service evaluation during admission for fragility femur fracture increases rates of bone health intervention and outpatient follow-up.
    Osteoporos Int. 2025 Jun 27. doi: 10.1007/s00198-025-07557.
    PubMed         Abstract available
    
    
13. LLOPIS-CARDONA F, Rodriguez-Bernal CL, Hurtado I, Espallargues M, et al
    Contemporary pharmacological management of patients after hip fracture: a population-based cohort of over 120,000 patients in Spain.
    Osteoporos Int. 2025 Jul 12. doi: 10.1007/s00198-025-07564.
    PubMed         Abstract available
    
    
14. DU X, Nouraie SM, Pu J, Karoleski C, et al
    Lung-related risk factors associate with low bone mineral density in individuals with former tobacco exposure not meeting osteoporosis screening criteria.
    Osteoporos Int. 2025 Aug 19. doi: 10.1007/s00198-025-07648.
    PubMed         Abstract available
    
    
15. LI CC, Ou LC, Chang YF, Chang CS, et al
    Performance and interventional cutoffs of osteoporosis self-assessment tools in the community: implications for screening and early referral.
    Osteoporos Int. 2025 Aug 20. doi: 10.1007/s00198-025-07656.
    PubMed         Abstract available
    
    
16. HARVEY NC, Al-Daghri N, Beaudart C, Brandi ML, et al
    Barriers and solutions for global access to osteoporosis management: a Position Paper from the International Osteoporosis Foundation.
    Osteoporos Int. 2025 Aug 22. doi: 10.1007/s00198-025-07628.
    PubMed         Abstract available
    
    
17. KO Y, Song BG, Shin H, Park Y, et al
    Correction: Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis.
    Osteoporos Int. 2025 Aug 22. doi: 10.1007/s00198-025-07649.
    PubMed        
    
    
18. JIN H, Jin H, Suk KS, Lee BH, et al
    Impact of anti-osteoporosis medication on refracture prevention following osteoporotic vertebral fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2025 Aug 22. doi: 10.1007/s00198-025-07661.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge.